Stem Cells

HighQC™ Human (Parental) Pancreatic Cancer Stem Cell

  • For research use only

Cat No.

ABC-SC0123

Product Type

Human Cancer Stem Cells

Cell Type

Stem Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Pancreas

Disease

Pancreatic Cancer

Storage

Liquid Nitrogen

Human (Parental) Pancreatic Cancer Stem Cell; Frozen Vial and Plated cells are available.

Product Image

Description

HighQC™ Human (Parental) Pancreatic Cancer Stem Cells are a population of tumor-initiating cells with stem cell-like properties associated with human pancreatic cancers. Morphologically, they exhibit a small, round to polygonal shape with high nucleus-to-cytoplasm ratios, growing in loosely adherent clusters or spheres in vitro. These cells are characterized by the expression of key cancer stem cell markers such as CD44, CD24, and ALDH1. They possess robust self-renewal capacity, recapitulating the heterogeneity of parental tumors by generating progeny with epithelial or mesenchymal phenotypes. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.

Product Code

HighQC™ Human (Parental) Pancreatic Cancer Stem Cell, Human Parental PCSC, hPara-PCSC, Human Pancreatic Cancer Progenitors

Species

Human

Cat.No

ABC-SC0123

Product Category

Stem Cells

Size/Quantity

1 vial

Cell Type

Stem Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Pancreas

Disease

Pancreatic Cancer

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Human Cancer Stem Cells

Application

  • HighQC™ Human (Parental) Pancreatic Cancer Stem Cells serve as a powerful tool for advancing pancreatic cancer research and therapeutic development. This pancreatic carcinoma CSC line is valuable for studying tumor initiation, metastasis, and drug resistance. In drug discovery, they enable high-throughput screening of novel compounds targeting cancer stem cell (CSC) pathways, such as Wnt, Notch, and Hedgehog inhibitors, to overcome therapy resistance.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring HighQC™ Human (Parental) Pancreatic Cancer Stem Cell

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button